Quick Answer
Amneal Pharmaceuticals, Inc. reported Net Income of $72.06 million for fiscal year 2025.
Amneal Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $72.06M | +161.6% |
| 2024 | -$116.89M | -39.2% |
| 2023 | -$83.99M | +69.0% |
| 2022 | -$270.58M | -2155.6% |
| 2021 | $13.16M | -80.6% |
| 2020 | $67.79M | +111.2% |
| 2019 | -$603.57M | -2957.0% |
| 2018 | -$19.74M | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.37M | +1618.6% | -89.4% |
| June 30, 2025 | $22.42M | +274.0% | +83.8% |
| March 31, 2025 | $12.20M | +113.3% | +7917.3% |
| September 30, 2024 | -$156.0K | -101.6% | -102.6% |
| June 30, 2024 | $5.99M | -49.7% | +106.5% |
| March 31, 2024 | -$91.64M | -1219.9% | -1046.5% |
| September 30, 2023 | $9.68M | +227.2% | -18.8% |
| June 30, 2023 | $11.92M | +104.9% | +271.6% |
- Amneal Pharmaceuticals, Inc. showed an increase of +161.6% in Net Income compared to the prior fiscal year.
- The most recent figure is from Amneal Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: